The ProCure22 (P22) Efficiency and Productivity Programme (EPP) Pre- and Post-Occupancy Evaluation toolkit can be used to assess realised benefits from UK healthcare projects.
Collaboration has been at the heart of the development of this tool, with all six Principal Supply Chain Partners (PSCPs) engaging with the Department of Health, NHS England, NHS Improvement, Principal Supply Chain Members (PSCMs), and NHS trusts, to develop a standardised approach to Post-Occupancy Evaluation (POE), while responding to Lord Carter’s efficiency and productivity drivers. All six PSCPs have committed to ensuring post-occupancy evaluations are undertaken and shared across all of their P22 schemes, at no additional cost to the NHS.
The P22 POE toolkit is available to all to use, without charge. P22 recognised the value in capturing benefits, through measurement and before-and-after assessment, to inform future developments. These common outputs, measured across physical measures – eg, floor areas, workload and activity, functionality and effectiveness, environmental and economic – bring together, in one toolkit, common measures enabling accurate scheme-to-scheme comparison and benchmarking. Current implementation at a national level will result in a body of knowledge and outcome measures, which have the potential to influence both national and international procurement, as well as providing direct comparison of healthcare building performance in use. A key component of the toolkit is the patient and staff surveys, which enable those at the front line experiencing new facilities to have a voice in their assessment.
The pre- and post-occupancy evaluations sit under the umbrella of the Government Soft Landings (GSL) P22 processes. They will be undertaken at appointment, and in years one, two and three following occupation. The data and commentary gathered should support the realisation of evidence benefits, as well as begin to inform and support new developments, while also assisting in identifying trends and areas requiring further design input or research. The potential of this toolkit is significant, both inside and outside of the P22 framework. It also offers an opportunity to demonstrate the UK’s position at the forefront of healthcare design toolkits, guidance and innovation.